【结 构 式】 |
【药物名称】Talarozole, R-115866, Rambazole 【化学名称】N-(2-Benzothiazolyl)-N-[4-[2-ethyl-1-(1,2,4-triazol-1- yl)butyl]phenyl]amine isomer B 【CA登记号】851811-31-9, 201410-67-5 ((-)-enantiomer), 201410-66-4 ((+)-enantiomer), 201410-53-9 (undefined isomer) 【 分 子 式 】C21H23N5S 【 分 子 量 】377.51496 |
【开发单位】Janssen (Originator) 【药理作用】DERMATOLOGIC DRUGS, ANTIPSORIATICS |
合成路线1
Addition of Grignard reagent (II) to N-(4-formylphenyl)acetamide (I) produced carbinol (III). After conversion of (III) to mesylate (IV), displacement with 1,2,4-triazole (V) afforded triazolyl derivative (VI). Acid hydrolysis of the acetamido group of (VI) furnished aniline (VII). Treatment of aniline (VII) with carbon disulfide and NaOH, followed by methylation with iodomethane, gave the bis(methylthio)methylene derivative (VIII). Alternatively, aniline (VII) was converted to isothiocyanate (IX) by reaction with thiophosgene. The title benzothiazole was finally obtained by condensation of 2-aminobenzenethiol (X) with either (VIII) or (IX).
【1】 Venet, M.G.; Mabire, D.J.-P.; Lacrampe, J.F.A.; Sanz, G.C. (Janssen Pharmaceutica NV); N-[4-(heteroarylmethyl)phenyl]-heteroarylamines. EP 0907650; JP 2000503670; US 6124330; WO 9749704 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 42212 | N-(4-formylphenyl)acetamide | 122-85-0 | C9H9NO2 | 详情 | 详情 |
(II) | 42213 | bromo(1-ethylpropyl)magnesium | C5H11BrMg | 详情 | 详情 | |
(III) | 42214 | N-[4-(2-ethyl-1-hydroxybutyl)phenyl]acetamide | C14H21NO2 | 详情 | 详情 | |
(IV) | 42215 | 1-[4-(acetamido)phenyl]-2-ethylbutyl methanesulfonate | C15H23NO4S | 详情 | 详情 | |
(V) | 13135 | 1H-1,2,4-Triazole; 1,2,4-Triazole | 288-88-0 | C2H3N3 | 详情 | 详情 |
(VI) | 42216 | N-[4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl]acetamide | C16H22N4O | 详情 | 详情 | |
(VII) | 42217 | 4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]aniline; 4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenylamine | C14H20N4 | 详情 | 详情 | |
(VIII) | 42218 | 1-[1-(4-[[bis(methylsulfanyl)methylene]amino]phenyl)-2-ethylbutyl]-1H-1,2,4-triazole | C17H24N4S2 | 详情 | 详情 | |
(IX) | 42219 | 1-[2-ethyl-1-(4-isothiocyanatophenyl)butyl]-1H-1,2,4-triazole; 4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl isothiocyanate | C15H18N4S | 详情 | 详情 | |
(X) | 25182 | 2-aminobenzenethiol | 137-07-5 | C6H7NS | 详情 | 详情 |
合成路线2
In a different procedure, N-(4-bromophenyl)-2-benzothiazolamine (XI) was converted into the lithio derivative and subsequently condensed with 2-ethylbutanal (XII) to give carbinol (XIII). Treatment of (XIII) with methanesulfonyl chloride and triethylamine provided mesylate (XIV), which was finally displaced by 1,2,4-triazole (V), yielding the title compound.
【1】 Venet, M.G.; Mabire, D.J.-P.; Lacrampe, J.F.A.; Sanz, G.C. (Janssen Pharmaceutica NV); N-[4-(heteroarylmethyl)phenyl]-heteroarylamines. EP 0907650; JP 2000503670; US 6124330; WO 9749704 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 13135 | 1H-1,2,4-Triazole; 1,2,4-Triazole | 288-88-0 | C2H3N3 | 详情 | 详情 |
(XI) | 42220 | N-(4-bromophenyl)-1,3-benzothiazol-2-amine; N-(1,3-benzothiazol-2-yl)-N-(4-bromophenyl)amine | C13H9BrN2S | 详情 | 详情 | |
(XII) | 42221 | 2-ethylbutanal | 97-96-1 | C6H12O | 详情 | 详情 |
(XIII) | 42222 | 1-[4-(1,3-benzothiazol-2-ylamino)phenyl]-2-ethyl-1-butanol | C19H22N2OS | 详情 | 详情 | |
(XIV) | 42223 | 1-[4-(1,3-benzothiazol-2-ylamino)phenyl]-2-ethylbutyl methanesulfonate | C20H24N2O3S2 | 详情 | 详情 |